Oregon GMO label advocates release first TV ads

The Yes on 92 campaign, the largest proponent of Oregon’s labeling measure, launched its first two ads on September 23.

The ad buy represents an early shot in what is expected to be an expensive battle. Last year’s more-than-$30-million fight over a similar measure in neighboring Washington turned into the most costly ballot contest in that state’s history, with roughly three of every four dollars raised coming in after Sept. 1, according to a review of contribution data. Local reports suggest the same may end up being true of the Oregon measure, with about $3 million raised on both sides so far, according to state data.

One ad features Oregon family farmers and another features Michael Hansen, senior scientist at Consumer Reports, the nonprofit that offers comprehensive product reviews.

“Our job is giving consumers unbiased information, so we’ve read the fine print and we strongly endorse Measure 92,” Hansen says in the ad embedded below. Labeling has not increased food costs in countries that have passed similar measures, and so it won’t in Oregon, he says.

Read full, original article: The biggest proponents of GMO labeling in Oregon launch their first ads

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
Screenshot-2026-05-11-104424
Hantavirus outbreak research: Trump administration shut down study last year on rodent-to-human transmission
Screenshot 2026-05-11 at 11.30
Despite politicized disinformation, Midwest AI data centers are fueling a solar energy boom
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
Screenshot-2026-05-08-at-3.40.33-PM
Seeds of power: China turns to genetic engineering to become global superpower
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
images
The never-ending GMO debate: Pros and cons
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.